BioE CEO Michael Haider Honored as a 2007 Twin Cities Business Biosciences Success Story

Haider recognized for company’s efforts to expand and strengthen the biosciences industry

ST. PAUL, Minn.  Sept. 6, 2007  BioE®, Inc., a biomedical company that provides enabling, high-quality human stem cells for drug discovery and therapeutic research, announced today company President and Chief Executive Officer Michael Haider is one of Twin Cities Business magazine’s 2007 BioSciences Success Stories.

“Our inaugural BioSciences Success Stories recognize individuals and companies who are expanding and strengthening Minnesota’s influence on the national and international biosciences scene,” said Jay Novak, publisher and editor for Twin Cities Business. “We are pleased to celebrate Michael Haider and BioE as one of five 2007 Minnesota BioSciences Success Stories as the company continues to play a pioneering role in the burgeoning fields of stem cell research and cord blood processing.”

“It’s an honor Twin Cities Business has recognized our efforts and success during the past year,” Haider said.  “Our cord blood-derived Multi-Lineage Progenitor Cell (MLPC) stem cell continues to rapidly gain favor among stem cell researchers and is now used by more than 100 academic research institutions, corporate laboratories and pharmaceutical organizations located around the world. Additionally, we recently brought to market our PrepaCyte-CB Cord Blood Processing System, which sets a new standard for obtaining therapeutically beneficial cells, including stem cells, from cord blood. We look forward to capitalizing on the market opportunities for each of our cord blood-related products, further solidifying BioE and Minnesota as leaders within the biosciences community.”

This year’s BioSciences Success Stories recipients were selected by the editorial staff of Twin Cities Business and are featured in the Minnesota BioSciences supplement within the magazine’s September issue. The 2007 honorees also will be recognized at an awards luncheon on Wed., Sept. 19, 2007 at the Nicollet Island Pavilion in Minneapolis.

Headquartered in St. Paul, Minn., BioE is a biomedical company that provides enabling, high-quality human stem cells for drug discovery and therapeutic research. The company’s novel Multi-Lineage Progenitor Cell™ (MLPC™) stem cell — derived from human umbilical cord blood and obtained using PrepaCyte®, the company’s proprietary cell isolation platform — provides clinicians and researchers a flexible, long-term and non-controversial tool for therapeutic research and drug discovery and screening. BioE is privately owned and was founded in 1993. For more information about the company, please visit www.bioe.com or call (800) 350-6466.